SARS-CoV-2

[Journal of Clinical Investigation] The authors highlight the current understanding, evolving concepts, and unanswered questions provided by this unique opportunity to determine mechanisms by which a viral infection can be exacerbated by, and even trigger, autoimmunity.

[Translational Research] There is little known about risk factors or predictors of susceptibility for Long-Hauler's Syndrome, but older adults are at greater risk for severe outcomes and mortality from COVID-19.

[Lipids in Health and Disease] Owing to antiviral, anti-inflammatory, immunomodulatory, and cardioprotective activity, statin therapy has been considered as valuable tool to improve COVID-19 outcomes.

[Nature Communications] Investigators developed a COVID-19 vaccine candidate based on Newcastle disease virus that could be manufactured at high yields in embryonated eggs.

[Cell Discovery] Scientists reported, besides generation of neutralizing antibodies, consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions in healthy volunteers after vaccination with an inactivated SARS-CoV-2 vaccine.

[Clinical & Translational Immunology] Researchers showed that primary human endothelial cells expressed very low levels of the SARS-CoV-2 receptor ACE2 and the protease TMPRSS2, which blocked their capacity for productive viral infection, and limited their capacity to produce infectious virus.